COVID-19 vaccine: Angela Merkel rejects the idea of blocking export

Last updated on February 6th, 2021 at 08:39 am

The European Union must protect vaccine supply chains. Angela Merkel strongly rejects the idea of ​​blocking or shunting vaccine exports to solve the problem of scarce supplies. And after a long, tense videoconference with the governors, the top ten pharmaceutical companies, including Pfizer, BioNTech, Curevac, AstraZeneca, and Johnson & Johnson, and the two European commissioners Stella Kyriakides and Thierry Breton, Merkel renewed their promise to offer a vaccine appointment by 21 September to all Germans.

Even if the vaccines don’t get the green light from Curevac and Johnson & Johnson. “Of course, if I’m 50 and not at risk, I’ll probably have to wait until summer,” Merkel explained, stressing that every German will have a date. The German Chancellor has confirmed her commitment to guarantee the vaccine to all its citizens by the end of the summer.

Angela Merkel had to admit that the bottlenecks in the coming weeks continue to be pitch black. And she did not rule out problems in the future too: “the pharmaceutical companies,” she admitted, “cannot give weekly commitments.”  Production and supply problems may also exist in the future. However, even if Michael Mueller, mayor of Berlin, has specified that “in the first quarter the supplies will be scarce, then there will be enough supplies to proceed in big steps with the vaccinations.” Germany plans to make up for lost time starting in spring. Merkel announced that from the strategy, Germany will move on to a vaccination plan, which must be drawn up by 10 February.

The Chancellor defended in a press conference the length of the EU Commission’s negotiations with pharmaceutical companies, the agreement signed at the end of August, on which a storm has hit Brussels for days. But it is interesting a passage reported by a source present at the meeting. When Merkel asked pharmaceutical companies whether an order agreed earlier or at a higher price would change anything, the BioNTech rep replied that “with more money, you wouldn’t have gotten much, nor with previous orders.”

Related Posts

However, the nervousness about European procedures is enormous. The governor of Bavaria, Markus Soeder (CSU), at one point, in the five-hour meeting, allegedly attacked the EU commissioners Kyriakides and Breton. The EU executive members have continued to defend the alleged transparency in supplies and have argued that “vaccinations are proceeding according to plan.” At that point, Soeder blurted out: “It is very difficult for me to consider what I have just heard from the EU as positive and satisfying.”

Victoria Hudson

Recent Posts

NATO Strengthens Eastern Flank Amid Rising Security Threats

NATO is also working faster to build up its eastern flank against the increasing security threats in border areas in… Read More

January 5, 2026

2026’s Most Anticipated Movies Set to Redefine the Global Box Office

Film enthusiasts are jumping into a blockbuster year with movie companies stacking franchise follow-ups, fresh movie worlds, and daring originals… Read More

January 5, 2026

Air Power as Punishment: How Saudi Strikes in Southern Yemen Are Tearing Communities Apart

Recent Saudi airstrikes in the southern part of Yemen cannot be shoved off as typical battlefield accidents and transient confrontations.… Read More

January 5, 2026

Travel Trends 2026: Where to Go and Avoid

Travel trends 2026 point to a more selective, value-driven traveler who plans earlier, stays longer, and avoids overcrowded hotspots. The… Read More

January 5, 2026

Trump Plans US Oil Firms to Invest Billions in Venezuela

Former US President Donald Trump is reportedly considering a plan that would allow US oil companies to invest billions in… Read More

January 5, 2026

The Rise of Deepfake Technology and How to Spot It

Deepfake technology has swiftly developed from a small-time AI experiment to a mass-scale online menace that affects politics, media, cybersecurity,… Read More

January 3, 2026

This website uses cookies.

Read More